Skip to content

AcrySof™ IQ Vivity™ DAT515 (REF DAT515.165)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV Absorbing Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652428668), received between Jul 2, 2021 and Apr 29, 2022 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Defective Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Defective Device1
  • Device Contamination with Chemical or Other Material1
  • Device Dislodged or Dislocated1

Patient problems

  • Blurred Vision2
  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 29, 2022Defective Device; Defective Device

    A NON-HEALTH PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT SURGERY, THE LENS FOUND TO BE DEFECTIVE.

    Patient problems: Insufficient Information

    MAUDE report 14254048 ↗
  • InjuryFeb 11, 2022Device Dislodged or Dislocated; Device Dislodged or Dislocated

    A NURSE REPORTED THAT AN INTRAOCULAR LENS (IOL) WAS EXPLANTED WITHIN 3 MONTH AFTER IMPLANTATION DUE TO BLURRY VISION AND IOL DISLOCATION. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Blurred Vision

    MAUDE report 13511903 ↗
  • MalfunctionNov 17, 2021Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    A SURGEON REPORTED THAT DURING A CATARACT EXTRACTION WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, A FIBER WAS FOUND FIBER ON THE LENS. THE FIBER WAS REMOVED DURING THE INITIAL PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED; HOWEVER, FURTHER INFORMATION HAS NOT BEEN RECEIVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12829078 ↗
  • InjuryJul 2, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON CUSTOMER REPRESENTATIVE REPORTED THAT AFTER AN INTRAOCULAR LENS WAS IMPLANTED, THE PATIENT EXPERIENCED BLURRY VISION AT DISTANCE AND NEAR. THE PATIENT WAS UNHAPPY WITH VISION . THE LENS WAS EXCHANGED FOR A DIFFERENT LENS 4 MONTHS AFTER INITIAL IMPLANTATION. DYSPHOTOPSIA OF IOL WAS THE CLINICAL REASON GIVEN FOR THE EXPLANT. ADDITIONAL INFORMATION REQUESTED.

    Patient problems: Blurred Vision

    MAUDE report 12106829 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page